Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease

Area of Science:

• Neurology
• Clinical Diagnostics
• Genetics

Background:

• Alzheimer disease diagnosis and monitoring present significant clinical challenges.
• Current diagnostic approaches involve analyzing cerebrospinal fluid biomarkers and genetic factors.

Purpose of the Study:

• To review current clinical laboratory testing for Alzheimer disease diagnosis.
• To discuss the progression monitoring capabilities of existing tests.

Main Methods:

• Analysis of amyloid and tau levels in cerebrospinal fluid.
• Examination of autosomal dominant and risk factor genes.

Main Results:

• Clinically available tests focus on specific biomarkers and genetic markers.
• Current methods are limited by the invasiveness of cerebrospinal fluid collection and genetic mutation rarity.

Conclusions:

• The field of Alzheimer disease diagnostics is rapidly evolving.
• Advancements in laboratory testing are expected to improve diagnostic and monitoring capabilities.